Cite
HARVARD Citation
Chi, K. et al. (n.d.). 2504 Genomic predictive and prognostic factors from plasma cell-free DNA (cfDNA) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) commencing enzalutamide (ENZ). European journal of cancer. pp. S474-S475. [Online].